Silence Therapeutics plc (OTCMKTS:SLNCF – Get Free Report)’s share price fell 32.7% during mid-day trading on Friday . The stock traded as low as $1.01 and last traded at $1.01. 2,700 shares traded hands during trading, an increase of 50% from the average session volume of 1,800 shares. The stock had previously closed at $1.50.
Silence Therapeutics Stock Performance
The company has a fifty day moving average price of $2.54 and a 200-day moving average price of $5.09.
Silence Therapeutics Company Profile
Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes in hematology, cardiovascular, and rare diseases. The company's mRNAi GalNAc Oligonucleotide Discovery platform consists of precision engineered product candidates designed to target specific disease-associated genes in the liver.
Recommended Stories
- Five stocks we like better than Silence Therapeutics
- Health Care Stocks Explained: Why You Might Want to Invest
- MP Materials: Rare Earth Elements Powering the EV Boom
- How to Most Effectively Use the MarketBeat Earnings Screener
- Verizon’s Turnaround Gains Traction: New Highs Are Likely in 2025
- Stock Average Calculator
- Bloom Energy: Powering the Future With Decentralized Energy
Receive News & Ratings for Silence Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silence Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
